Chiral cis-imidazolines
US7964724B2 · kind B2 · utility
20Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2005 |
| Grant date | Jun 21, 2011 |
| Priority date | — |
| Expiry date | May 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/26
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
and the pharmaceutically acceptable salts and esters thereof, wherein X1, X2, X3, Y1, Y2 and R are described herein inhibit the interaction of MDM2 protein with a p53-like peptide and hence have anti proliferative activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.